|4Jan 4, 8:30 AM ET

Berman Howard 4

4 · Coya Therapeutics, Inc. · Filed Jan 4, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Berman Howard
DirectorExecutive Chairman
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2023-01-03+10,00010,000 total
  • Purchase

    Warrant to Purchase Common Stock

    2023-01-03+5,0005,000 total
    Exercise: $7.50From: 2023-01-03Exp: 2025-01-03Common Stock, par value $0.0001 per share (5,000 underlying)
Holdings
  • Common Stock, par value $0.0001 per share

    (indirect: By LLC)
    949,338
Footnotes (2)
  • [F1]Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant.
  • [F2]Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Documents

1 file
  • 4
    ownership.xmlPrimary